Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

Background: Statin medications reduce the risk of atherosclerotic cardiovascular disease (ASCVD). China’s new central government medicine procurement policy lowered statin prices by five-fold or more, which may impact the cost-effectiveness of statin therapy. Objective: To explore the impact of Chin...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Miao Wang, Jing Liu, Brandon K. Bellows, Yue Qi, Jiayi Sun, Jun Liu, Andrew E. Moran, Dong Zhao
Format: Artigo
Jezik:Inglês
Izdano: Ubiquity Press 2020-06-01
Serija:Global Heart
Teme:
cardiovascular disease
cost-effectiveness
low-density lipoprotein cholesterol
microsimulation
primary prevention
statins
Online pristup:https://globalheartjournal.com/articles/830
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items